Annual Working Capital
$505.53 M
+$166.79 M+49.24%
December 31, 2023
Summary
- As of February 7, 2025, IDYA annual working capital is $505.53 million, with the most recent change of +$166.79 million (+49.24%) on December 31, 2023.
- During the last 3 years, IDYA annual working capital has risen by +$255.57 million (+102.24%).
- IDYA annual working capital is now at all-time high.
Performance
IDYA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$891.55 M
+$219.12 M+32.59%
September 30, 2024
Summary
- As of February 7, 2025, IDYA quarterly working capital is $891.55 million, with the most recent change of +$219.12 million (+32.59%) on September 30, 2024.
- Over the past year, IDYA quarterly working capital has increased by +$386.02 million (+76.36%).
- IDYA quarterly working capital is now at all-time high.
Performance
IDYA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IDYA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.2% | +76.4% |
| 3 y3 years | +102.2% | +76.4% |
| 5 y5 years | +493.0% | +985.7% |
IDYA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +145.6% | at high | +347.8% |
| 5 y | 5-year | at high | +433.7% | at high | +985.7% |
| alltime | all time | at high | +4437.2% | at high | +1102.9% |
IDEAYA Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $891.55 M(+32.6%) |
| Jun 2024 | - | $672.44 M(-1.7%) |
| Mar 2024 | - | $684.39 M(+35.4%) |
| Dec 2023 | $505.53 M(+49.2%) | $505.53 M(+10.5%) |
| Sep 2023 | - | $457.29 M(-4.0%) |
| Jun 2023 | - | $476.45 M(+51.7%) |
| Mar 2023 | - | $314.14 M(-7.3%) |
| Dec 2022 | $338.74 M(+64.6%) | $338.74 M(-6.1%) |
| Sep 2022 | - | $360.71 M(+68.5%) |
| Jun 2022 | - | $214.10 M(+7.5%) |
| Mar 2022 | - | $199.09 M(-3.3%) |
| Dec 2021 | $205.84 M | $205.84 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $230.33 M(-5.6%) |
| Jun 2021 | - | $244.02 M(-10.3%) |
| Mar 2021 | - | $272.03 M(+8.8%) |
| Dec 2020 | $249.97 M(+163.9%) | $249.97 M(+10.0%) |
| Sep 2020 | - | $227.16 M(+36.4%) |
| Jun 2020 | - | $166.52 M(+102.8%) |
| Mar 2020 | - | $82.12 M(-13.3%) |
| Dec 2019 | $94.71 M(+11.1%) | $94.71 M(-10.8%) |
| Sep 2019 | - | $106.21 M(-8.6%) |
| Jun 2019 | - | $116.16 M(+56.7%) |
| Mar 2019 | - | $74.12 M(-13.1%) |
| Dec 2018 | $85.25 M(+665.2%) | $85.25 M |
| Dec 2017 | $11.14 M | - |
FAQ
- What is IDEAYA Biosciences annual working capital?
- What is the all time high annual working capital for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual working capital year-on-year change?
- What is IDEAYA Biosciences quarterly working capital?
- What is the all time high quarterly working capital for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly working capital year-on-year change?
What is IDEAYA Biosciences annual working capital?
The current annual working capital of IDYA is $505.53 M
What is the all time high annual working capital for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual working capital is $505.53 M
What is IDEAYA Biosciences annual working capital year-on-year change?
Over the past year, IDYA annual working capital has changed by +$166.79 M (+49.24%)
What is IDEAYA Biosciences quarterly working capital?
The current quarterly working capital of IDYA is $891.55 M
What is the all time high quarterly working capital for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly working capital is $891.55 M
What is IDEAYA Biosciences quarterly working capital year-on-year change?
Over the past year, IDYA quarterly working capital has changed by +$386.02 M (+76.36%)